Wei, Xiaoqian
Pan, Shushan
Wang, Zirui
Chen, Jieru
Lu, Li
Cao, Qizhi
Song, Shuling
Zhang, Huachang
Liu, Xiaohui
Qu, Xianjun
Lin, Xiukun
Xu, Huanli https://orcid.org/0000-0002-4599-9271
Article History
Received: 22 May 2023
Revised: 19 September 2023
Accepted: 28 September 2023
First Online: 16 October 2023
Competing interests
: The authors declare no competing interests.
: Informed consent and ethical approval of the human glioma tissue chip were obtained from the Ethics Committee of Shanghai Outdo Biotechnology Company (YBM-05-02). The animal experiments were approved by the Committee of Animal Experiments and Experimental Animal Welfare of the Capital Medical University in Beijing, China (no. AEEI-2019078 and 37363), and performed in accordance with the local institutional guidelines and ethics.